Generic Name | Brand Name | Pharmacology | 2008 FDA Approved Indication | Pharmacologically Similar Agents | |
Bendamustine | Treanda | alkylating agent | Treatment of chronic lymphocytic leukemia | busulfan, carmustine, chlorambucil, cyclophosphamide, ifosfamide, melphalan | |
Certolizumab | Cimzia | tumor necrosis factor inhibitor | infliximab | ||
Clevidipine | Cleviprex | dihydropyridine calcium channel antagonist | Treatment of hypertension | amlodipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine nisoldipine | |
Degarelix | none | GnRH receptor antagonist | Treatment of prostate cancer | goserelin, histrelin, leuprolide, triptorelin | |
Desvenlafaxine (major metabolite of venlafaxine) | Pristiq | selective serotonin and norepinephrine reuptake inhibitor | Treatment of major depressive disorder | venlafaxine | |
Difluprednate | Durezol | opthalmic corticosteroid | Treatment of ocular inflammation | prednisolone | |
ethinyl estradiol/levonorgestrel | LoSeasonique | oral contraceptive | Prevention of pregnancy | ethinyl estradiol/levonorgestrel (Seasonique) | |
Etravirine | Intelence | non-nucleoside reverse transcriptase inhibitor | Treatment of HIV-1 infection | delavridine, efavirenz, nevirapine | |
Fesoterodine | Toviaz | muscarinic receptor antagonist | Treatment of overactive bladder | darifenacin, solifenacin, tolterodine | |
Fosaprepitant (produrg of aprepitant) | Emend | substance P/neurokinin 1 receptor antagonist | Prevention of nausea and vomiting associated with emetogenic cancer chemotherapy | aprepitant | |
Fospropofol (produrg of propofol) | Lusedra | sedative-hypnotic | Monitored anesthesia care sedation | propofol | pages 350-351 |
gadofosveset | Vasovist | gadolinium-based contrast agent | Magnetic resonance imaging | gadodiamide, gadoteridol | |
gadoxetate | |||||
Regadenoson | Lexiscan | adenosine receptor agonist | Pharmacologic stress agent for radionuclide myocardial perfusion imaging | adenosine | page 917 |
Rilonacept (also known as IL-1 Trap) | Arcalyst | interleukin-1 blocker | Treatment of cryopyrin-associated periodic syndromes, including Familial Cold Autoinflammatory Syndrome and Muckle-Wells Syndrome | anakinra | page 672 |
Silodosin | Rapaflo | alpha-1 adrenergic receptor antagonist | Treatment of benign prostatic hyperplasia | prazosin, terazosin, doxazosin, tamsulosin, alfuzosin | pages 269-271 |
Tapentadol | none | m-opioid receptor agonist & norepinephrine reuptake inhibittor | Relief of pain | tramadol | page 566 |
Tetrabenazine | Xenazine | monoamine depletor | Treatment of chorea associated with Huntington’s disease | reserpine | pages 173, 541 |
Welcome to the Collection of PGMEENotes for Medical PG Entrance Examinations including AIIMS All-India PGI Kerala PGMEE
Monday, May 11, 2009
Drugs Licensed in 2008 with Mechanisms Similar to Previously Approved Drugs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Please add your comments or suggestions here..
Note: Only a member of this blog may post a comment.